Skip to content Print

MedixMAB Carcinoembryonic Antigen (CEA)

Human CEA is also included in the wide range of MedixMAB tumor markers

About CEA / Carcinoembryonic Antigen

Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, but elevated levels have been found in individuals with carcinomas. CEA measurement is mainly used as a tumor marker to identify recurrences after surgical resection. CEA levels may also me raised in some non-neoplastic conditions like ulcerative colitis, pancreatitis and cirrhosis.

Product Specifications Sheets

Product name   

Product Code

Product Specification Sheet

  • Anti-h CEA clone 5905   

100044

  • Anti-h CEA clone 5909

100046

  • Anti-h CEA clone 5910

100047

  • Anti-h CEA clone 5911

100048

  • Anti-h CEA clone 5912

100049

 

Scientific articles in which MedixMAB CEA monoclonals have been used

 
  • Bhayana V and Diamandis EP (1989). A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen is serum.Clin. Biochem., 22:433-438.
  • Hammarström S et al (1989). Antigenic sites in carcinoembryonic antigen. Cancer Res. 49:4852-4858.
 


 

Back to top